Jen Can NuSH flags two new trials without placebo arms, one for the GLP-1/glucagon drug survodutide and one for Pfizer's GLP-1 berobenatide.
Recap by typeshit. Post by @JCanNuSH on X.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Korea's drug safety ministry asked regulators to block the posts, most of which sold the drugs directly or linked to sales sites. Officials warned of counterfeit risk.
Australian anaesthetists urge patients to disclose GLP-1s or gym peptides before surgery. The UK study of 47,000 patients says the link isn't necessarily causal.
Loading…